Mechanistic study of the azithromycin dosage-form-dependent food effect

Pharmaceutical Research

Volumn 27, Issue 7, 2010, Pages 1361-1366

  Curatolo, William ^a   Foulds, George ^a   Labadie, Robert ^a  

^a PFIZER INC   (United States)

Author keywords

Azithromycin; Capsule disintegration; Des cladinose azithromycin; Food effect

Indexed keywords

AZITHROMYCIN; DRUG DOSAGE FORM; MICROCAPSULE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DETERMINATION; DRUG STRUCTURE; FEMALE; FOOD DRUG INTERACTION; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SYSTEMIC THERAPY; TABLET FORMULATION; TIME TO MAXIMUM PLASMA CONCENTRATION; BIOAVAILABILITY; BLOOD; CHEMICAL STRUCTURE; DRUG DOSAGE FORM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROCAPSULE;

ADULT; AREA UNDER CURVE; AZITHROMYCIN; BIOLOGICAL AVAILABILITY; CAPSULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; DOSAGE FORMS; FASTING; FEMALE; FOOD-DRUG INTERACTIONS; HUMANS; MALE; MOLECULAR STRUCTURE;

EID: 77953621895     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0126-6     Document Type: Article

References (21)

1. G Foulds RM Shepard RB Johnson 1990 The pharmacokinetics of azithromycin in human serum and tissues J Antimicrob Chemother 25 Suppl. A 73 82 1:CAS:528:DyaK3cXhtlWrsbc%3D 2154441
2. Gardner MJ, Ronfeld R. Interpretation and characterization of the pharmacokinetics of azithromycin in man. In: Program and Abstracts of the Eighth Mediterranean Congress of Chemotherapy 1992. Athens, Greece; 1992. p. 302, Abstract 407.
3. DR Luke G Foulds SF Cohen B Levy 1996 Safety, toleration, and pharmacokinetics of intravenous azithromycin Antimicrob Agents Chemother 40 2577 2581 1:CAS:528:DyaK28Xms1Smsbo%3D 8913468
4. G Foulds RB Johnson 1993 Selection of dose regimens of azithromycin J Antimicrob Chemother 31 Suppl. E 39 50 8396095
5. W Curatolo 1998 Physical chemical properties of oral drug candidates in the discovery and exploratory development settings Pharm Sci Tech Today 1 387 393 10.1016/S1461-5347(98)00097-2 1:CAS:528:DC%2BD3cXptlWjtg%3D%3D (Pubitemid 28559133)
6. Foulds G, Connolly A, Fortner J, Fletcher A. Separation of presystemic and post-absorptive influences on the bioavailability of azithromycin in cynomolgus monkeys. In: Zinner SH, editor. Expanding Indications for the New Macrolides, Azalides, and Spectrogramins. New York: Marcel Dekker Inc; 1997. p. 460-3.
7. G Foulds DR Luke R Teng SA Willavize H Friedman W Curatolo 1996 The absence of an effect of food on the bioavailability of azithromycin administered as tablets, sachet or suspension J Antimicrob Chemother 37 Suppl. C 37 44 1:CAS:528:DyaK28XktlOit7k%3D 8818844
8. Foulds G, Luke DR, Willavize SA, Curatolo W, Friedman H, Gardner MJ et al. Effect of food and formulation on bioavailability of azithromycin. In: Zinner SH, editor. Expanding Indications for the New Macrolides, Azalides, and Spectrogramins. New York: Marcel Dekker Inc; 1997. p. 469-73.
9. Curatolo W, Foulds G, Friedman H. Method of dosing azithromycin. U.S. Patent #5,605,899. European Patent EP-0679400B1; 1995. Published Nov. 2, 1995.
10. EF Fiese SH Steffen 1990 Comparison of the acid stability of azithromycin and erythromycin A J Antimicrob Chemother 25 Suppl. A 39 47 1:CAS:528:DyaK3cXhvVGlt7o%3D 2154437
11. Guidance for Industry. Food-Effect Bioavailability and Fed Bioequivalence Studies. U.S. Department of Health and Human Services, FDA, CDER; 2002.
12. R Shepard F Falkner 1990 Pharmacokinetics of azithromycin in rats and dogs J Antimicrob Chemother 25 Suppl. A 49 60 1:CAS:528:DyaK3cXhtFWnurg%3D 2154438
13. J Dressman R Berardi L Dermentzoglou T Russell S Schmaltz J Barnett K Jarvenpaa 1990 Upper gastrointestinal (GI) pH in young, healthy men and women Pharm Res 7 756 761 10.1023/A:1015827908309 1:CAS:528:DyaK3cXltFejsbw%3D 2395805 (Pubitemid 20278376)
14. DR Luke G Foulds 1997 Disposition of oral azithromycin in humans Clin Pharmacol Therapeutics 61 641 648 10.1016/S0009-9236(97)90098-9 1:CAS:528:DyaK2sXkslalt7s%3D (Pubitemid 27279925)
15. D Casey R Beihn G Digenis M Shambu 1976 Method for monitoring hard gelatin capsule disintegration times in humans using external scintigraphy J Pharm Sci 65 1412 1413 10.1002/jps.2600650941 1:CAS:528:DyaE28XlsV2jt7k%3D 966168
16. Chidlaw M, Friesen D, Herbig S, Nightingale J, Oksanen C, West JB. Controlled release of an active substance into a high fat environment. International Patent Application WO-2004/052343; 2004.
17. L Kalantzi R Page E Nicolaides G Digenis C Reppas 2008 In vitro methods can forecast the effects of intragastric residence on dosage form performance Eur J Pharmaceut Sci 33 445 451 10.1016/j.ejps.2008.01.014 1:CAS:528: DC%2BD1cXktlGjs7w%3D
18. A Diakidou M Vertzoni B Abrahamsson J Dressman C Reppas 2009 Simulation of gastric lipolysis and prediction of felodipine release from a matrix tablet in the fed stomach Eur J Pharmaceut Sci 37 133 140 10.1016/j.ejps.2009.02.003 1:CAS:528:DC%2BD1MXjvV2ms70%3D
19. B Abrahamsson T Albery A Eriksson I Gustafsson M Sjoberg 2004 Food effects on tablet disintegration Eur J Pharmaceut Sci 22 165 172 10.1016/j.ejps.2004.03.004 1:CAS:528:DC%2BD2cXkt1Sltbc%3D (Pubitemid 38668681)
20. P Macheras M Koupparis C Tsaprounis 1986 Drug dissolution studies in milk using the automated flow injection serial dynamic dialysis technique Int J Pharmaceut 33 125 136 10.1016/0378-5173(86)90046-3 1:CAS:528: DyaL2sXjvVeltw%3D%3D (Pubitemid 17197796)
21. K Kelly B O'Mahony B Lindsay T Jones TJ Grattan A Rostami-Hodjegan H Stevens C Wilson 2003 Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma-scintigraphy Pharm Res 20 1668 1673 10.1023/A:1026155822121 1:CAS:528:DC%2BD3sXotFCls7c%3D 14620524 (Pubitemid 37268285)